---
title: "LEAGUER: The synthetic biology heavyweight platform has successfully landed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230774190.md"
description: "LEAGUER successfully held the unveiling ceremony of the synthetic biology industry mass conversion platform at its innovation center. The platform aims to gather upstream and downstream enterprises in the synthetic biology industry to promote regional industrial development. By integrating resources from research institutions, universities, and the industry, it builds an ecosystem for technology research and development, achievement transformation, industrial incubation, and market promotion, facilitating the commercialization of technological achievements"
datetime: "2025-03-06T06:47:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230774190.md)
  - [en](https://longbridge.com/en/news/230774190.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230774190.md)
---

# LEAGUER: The synthetic biology heavyweight platform has successfully landed

Recently, the unveiling ceremony of the synthetic biology industry mass conversion platform was successfully held at the LEAGUER Innovation Center. This platform aims to gather upstream and downstream enterprises in the synthetic biology industry to jointly promote the vigorous development of the regional synthetic biology industry. The platform will rely on LEAGUER's technological innovation resources and regional industrial advantages, closely integrating research institutions, higher education institutions, and the industry to jointly build an ecosystem that encompasses technology research and development, achievement transformation, industry incubation, and market promotion, bridging the "last mile" of technology achievements from the laboratory to the market, achieving a seamless connection from "shelf" to "shelf"

### Related Stocks

- [002243.CN](https://longbridge.com/en/quote/002243.CN.md)

## Related News & Research

- [SGS expands Saint-Benoît bioanalytical lab in France by 500 sq m](https://longbridge.com/en/news/295666502.md)
- [Is Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance?](https://longbridge.com/en/news/295324260.md)
- [Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study](https://longbridge.com/en/news/295661585.md)
- [Clene says ALS biomarker analyses show CNM-Au8 survival benefit in NfL responders](https://longbridge.com/en/news/295404884.md)
- [Datasea registers, lists NeuroVibe biofeedback system with FDA as Class II 510(k)-exempt device](https://longbridge.com/en/news/295541382.md)